Literature DB >> 30076409

RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.

Homa Rahnamoun1, Jihoon Lee1, Zhengxi Sun1, Hanbin Lu1, Kristen M Ramsey2, Elizabeth A Komives2, Shannon M Lauberth3.   

Abstract

The bromodomain and extra-terminal motif (BET) protein BRD4 binds to acetylated histones at enhancers and promoters via its bromodomains (BDs) to regulate transcriptional elongation. In human colorectal cancer cells, we found that BRD4 was recruited to enhancers that were co-occupied by mutant p53 and supported the synthesis of enhancer-directed transcripts (eRNAs) in response to chronic immune signaling. BRD4 selectively associated with eRNAs that were produced from BRD4-bound enhancers. Using biochemical and biophysical methods, we found that BRD4 BDs function cooperatively as docking sites for eRNAs and that the BDs of BRD2, BRD3, BRDT, BRG1, and BRD7 directly interact with eRNAs. BRD4-eRNA interactions increased BRD4 binding to acetylated histones in vitro and augmented BRD4 enhancer recruitment and transcriptional cofactor activities. Our results suggest a mechanism by which eRNAs are directly involved in gene regulation by modulating enhancer interactions and transcriptional functions of BRD4.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30076409      PMCID: PMC6859054          DOI: 10.1038/s41594-018-0102-0

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  60 in total

1.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

2.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

3.  eRNAs are required for p53-dependent enhancer activity and gene transcription.

Authors:  Carlos A Melo; Jarno Drost; Patrick J Wijchers; Harmen van de Werken; Elzo de Wit; Joachim A F Oude Vrielink; Ran Elkon; Sónia A Melo; Nicolas Léveillé; Raghu Kalluri; Wouter de Laat; Reuven Agami
Journal:  Mol Cell       Date:  2012-12-27       Impact factor: 17.970

4.  Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.

Authors:  Kyoko L Yap; Side Li; Ana M Muñoz-Cabello; Selina Raguz; Lei Zeng; Shiraz Mujtaba; Jesús Gil; Martin J Walsh; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

5.  Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.

Authors:  Erik Arner; Carsten O Daub; Kristoffer Vitting-Seerup; Robin Andersson; Berit Lilje; Finn Drabløs; Andreas Lennartsson; Michelle Rönnerblad; Olga Hrydziuszko; Morana Vitezic; Tom C Freeman; Ahmad M N Alhendi; Peter Arner; Richard Axton; J Kenneth Baillie; Anthony Beckhouse; Beatrice Bodega; James Briggs; Frank Brombacher; Margaret Davis; Michael Detmar; Anna Ehrlund; Mitsuhiro Endoh; Afsaneh Eslami; Michela Fagiolini; Lynsey Fairbairn; Geoffrey J Faulkner; Carmelo Ferrai; Malcolm E Fisher; Lesley Forrester; Daniel Goldowitz; Reto Guler; Thomas Ha; Mitsuko Hara; Meenhard Herlyn; Tomokatsu Ikawa; Chieko Kai; Hiroshi Kawamoto; Levon M Khachigian; S Peter Klinken; Soichi Kojima; Haruhiko Koseki; Sarah Klein; Niklas Mejhert; Ken Miyaguchi; Yosuke Mizuno; Mitsuru Morimoto; Kelly J Morris; Christine Mummery; Yutaka Nakachi; Soichi Ogishima; Mariko Okada-Hatakeyama; Yasushi Okazaki; Valerio Orlando; Dmitry Ovchinnikov; Robert Passier; Margaret Patrikakis; Ana Pombo; Xian-Yang Qin; Sugata Roy; Hiroki Sato; Suzana Savvi; Alka Saxena; Anita Schwegmann; Daisuke Sugiyama; Rolf Swoboda; Hiroshi Tanaka; Andru Tomoiu; Louise N Winteringham; Ernst Wolvetang; Chiyo Yanagi-Mizuochi; Misako Yoneda; Susan Zabierowski; Peter Zhang; Imad Abugessaisa; Nicolas Bertin; Alexander D Diehl; Shiro Fukuda; Masaaki Furuno; Jayson Harshbarger; Akira Hasegawa; Fumi Hori; Sachi Ishikawa-Kato; Yuri Ishizu; Masayoshi Itoh; Tsugumi Kawashima; Miki Kojima; Naoto Kondo; Marina Lizio; Terrence F Meehan; Christopher J Mungall; Mitsuyoshi Murata; Hiromi Nishiyori-Sueki; Serkan Sahin; Sayaka Nagao-Sato; Jessica Severin; Michiel J L de Hoon; Jun Kawai; Takeya Kasukawa; Timo Lassmann; Harukazu Suzuki; Hideya Kawaji; Kim M Summers; Christine Wells; David A Hume; Alistair R R Forrest; Albin Sandelin; Piero Carninci; Yoshihide Hayashizaki
Journal:  Science       Date:  2015-02-12       Impact factor: 47.728

Review 6.  Lysine acetylation and the bromodomain: a new partnership for signaling.

Authors:  Xiang-Jiao Yang
Journal:  Bioessays       Date:  2004-10       Impact factor: 4.345

7.  Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.

Authors:  Z Zou; B Huang; X Wu; H Zhang; J Qi; J Bradner; S Nair; L-F Chen
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

8.  An atlas of active enhancers across human cell types and tissues.

Authors:  Robin Andersson; Claudia Gebhard; Michael Rehli; Albin Sandelin; Irene Miguel-Escalada; Ilka Hoof; Jette Bornholdt; Mette Boyd; Yun Chen; Xiaobei Zhao; Christian Schmidl; Takahiro Suzuki; Evgenia Ntini; Erik Arner; Eivind Valen; Kang Li; Lucia Schwarzfischer; Dagmar Glatz; Johanna Raithel; Berit Lilje; Nicolas Rapin; Frederik Otzen Bagger; Mette Jørgensen; Peter Refsing Andersen; Nicolas Bertin; Owen Rackham; A Maxwell Burroughs; J Kenneth Baillie; Yuri Ishizu; Yuri Shimizu; Erina Furuhata; Shiori Maeda; Yutaka Negishi; Christopher J Mungall; Terrence F Meehan; Timo Lassmann; Masayoshi Itoh; Hideya Kawaji; Naoto Kondo; Jun Kawai; Andreas Lennartsson; Carsten O Daub; Peter Heutink; David A Hume; Torben Heick Jensen; Harukazu Suzuki; Yoshihide Hayashizaki; Ferenc Müller; Alistair R R Forrest; Piero Carninci
Journal:  Nature       Date:  2014-03-27       Impact factor: 49.962

9.  BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.

Authors:  Helen Jayne Susan Stewart; Gillian Abigail Horne; Sarah Bastow; Timothy James Telfer Chevassut
Journal:  Cancer Med       Date:  2013-10-31       Impact factor: 4.452

10.  DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.

Authors:  Emma A Morrison; Julio C Sanchez; Jehnna L Ronan; Daniel P Farrell; Katayoun Varzavand; Jenna K Johnson; Brian X Gu; Gerald R Crabtree; Catherine A Musselman
Journal:  Nat Commun       Date:  2017-07-14       Impact factor: 14.919

View more
  50 in total

Review 1.  Non-coding RNAs in chromatin folding and nuclear organization.

Authors:  Sergey V Razin; Alexey A Gavrilov
Journal:  Cell Mol Life Sci       Date:  2021-06-11       Impact factor: 9.261

2.  The role of enhancer RNAs in epigenetic regulation of gene expression.

Authors:  Homa Rahnamoun; Paola Orozco; Shannon M Lauberth
Journal:  Transcription       Date:  2019-12-11

3.  Lessons from eRNAs: understanding transcriptional regulation through the lens of nascent RNAs.

Authors:  Joseph F Cardiello; Gilson J Sanchez; Mary A Allen; Robin D Dowell
Journal:  Transcription       Date:  2019-12-19

4.  Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.

Authors:  Joo-Hyung Lee; Feng Xiong; Wenbo Li
Journal:  RNA Biol       Date:  2020-01-19       Impact factor: 4.652

5.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

Review 6.  Enhancer RNAs are an important regulatory layer of the epigenome.

Authors:  Vittorio Sartorelli; Shannon M Lauberth
Journal:  Nat Struct Mol Biol       Date:  2020-06-08       Impact factor: 15.369

7.  The molecular basis of selective DNA binding by the BRG1 AT-hook and bromodomain.

Authors:  Julio C Sanchez; Liyang Zhang; Stefania Evoli; Nicholas J Schnicker; Maria Nunez-Hernandez; Liping Yu; Jeff Wereszczynski; Miles A Pufall; Catherine A Musselman
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-05-03       Impact factor: 4.490

Review 8.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

9.  RNA-Mediated Feedback Control of Transcriptional Condensates.

Authors:  Jonathan E Henninger; Ozgur Oksuz; Krishna Shrinivas; Ido Sagi; Gary LeRoy; Ming M Zheng; J Owen Andrews; Alicia V Zamudio; Charalampos Lazaris; Nancy M Hannett; Tong Ihn Lee; Phillip A Sharp; Ibrahim I Cissé; Arup K Chakraborty; Richard A Young
Journal:  Cell       Date:  2020-12-16       Impact factor: 41.582

Review 10.  Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation.

Authors:  Tim Y Hou; W Lee Kraus
Journal:  Trends Biochem Sci       Date:  2020-09-01       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.